CTOs on the Move


 
Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company`s mission is to advance the care of patients suffering from life-threatening diseases. Gilead has operations in more than 30 countries worldwide, with headquarters in Foster City, California.
  • Number of Employees: 10K-50K
  • Annual Revenue: > $1 Billion
  • www.gilead.com
  • 333 Lakeside Drive
    Foster City, CA USA 94404
  • Phone: 650.574.3000

Executives

Name Title Contact Details
Anna Asberg
SVP IT and global CIO Profile
Allison Sands
Vice President Corporate Security and Profile
Marc Berson
Senior Vice President and Chief Information Officer Profile
Bill Merritt
Principal IT Security Architect, Security and Privacy Profile
Varun Goel
IT Security and Risk Associate Director Profile

Similar Companies

NVE Pharmaceuticals

NVE Pharmaceuticals is a Andover, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Global Pharmaceutical Corp

Global Pharmaceutical Corp is a Chalfont, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Provident Research

Provident Research is a Rockville, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

DocRx

At DocRX we help doctors and hospitals become more efficient, and profitable. We also help make them compliant with regulations. Visit us today!

Flowr Corporation

The Flowr Corporation is a global cannabis company that exists to cultivate better people, plants and products. Based in Toronto, we operate globally in Canada, Europe and Australia. In Canada, our operating campus in Kelowna, BC is situated in the Okanagan Valley, an epicentre of cannabis cultivation. This campus produces recreational and medicinal cannabis from a purpose-built, GMP-designed indoor cultivation facility, an outdoor and greenhouse cultivation site, and (soon to open) state-of-the-art R&D facility. Internationally, The Flowr Corporation will meet growing global medicinal cannabis demand through its subsidiary Holigen. Licensed to cultivate in Portugal, Holigen will operate GMP-designed cultivation facilities in both Portugal and Australia. Our goal is to be the #1 choice of consumers and patients alike, and our established experts in cannabis cultivation, regulated industries and consumer goods aim to meet that goal responsibly, everywhere we operate.